NFE2L2 and cancer: Taken together, these results suggested that the p62-Nrf2 antioxidant pathway reacted to hypoxia- or cancer cell-mediated oxidative stresses by activating the cellular differentiation into the CAF phenotype, as a stress defense mechanism.